ATE203273T1 - Inhibitoren einer protease, die den löslichen p55-tnf-rezeptor vom zellgebundenen tnf-rezeptor abspaltet - Google Patents

Inhibitoren einer protease, die den löslichen p55-tnf-rezeptor vom zellgebundenen tnf-rezeptor abspaltet

Info

Publication number
ATE203273T1
ATE203273T1 AT94116018T AT94116018T ATE203273T1 AT E203273 T1 ATE203273 T1 AT E203273T1 AT 94116018 T AT94116018 T AT 94116018T AT 94116018 T AT94116018 T AT 94116018T AT E203273 T1 ATE203273 T1 AT E203273T1
Authority
AT
Austria
Prior art keywords
tnf receptor
cell
inhibitors
bound
soluble
Prior art date
Application number
AT94116018T
Other languages
English (en)
Inventor
David Wallach
Cord Brackebusch
Eugene Varfolomeev
Michael Batkin
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE203273T1 publication Critical patent/ATE203273T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
AT94116018T 1993-10-12 1994-10-11 Inhibitoren einer protease, die den löslichen p55-tnf-rezeptor vom zellgebundenen tnf-rezeptor abspaltet ATE203273T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL107268A IL107268A0 (en) 1993-10-12 1993-10-12 Molecules influencing the shedding of the tnf receptor, their preparation and their use

Publications (1)

Publication Number Publication Date
ATE203273T1 true ATE203273T1 (de) 2001-08-15

Family

ID=11065340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94116018T ATE203273T1 (de) 1993-10-12 1994-10-11 Inhibitoren einer protease, die den löslichen p55-tnf-rezeptor vom zellgebundenen tnf-rezeptor abspaltet

Country Status (13)

Country Link
US (2) US5665859A (de)
EP (1) EP0657536B1 (de)
JP (1) JPH07194376A (de)
AT (1) ATE203273T1 (de)
AU (1) AU679559B2 (de)
CA (1) CA2133872A1 (de)
DE (1) DE69427740T2 (de)
DK (1) DK0657536T3 (de)
ES (1) ES2163418T3 (de)
GR (1) GR3036782T3 (de)
IL (1) IL107268A0 (de)
PT (1) PT657536E (de)
ZA (1) ZA947962B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264944B1 (en) * 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
JPH03164179A (ja) * 1989-04-21 1991-07-16 Boehringer Ingelheim Internatl Gmbh Ｔｎｆレセプター、ｔｎｆ結合たん白質およびこれらをコードするｄｎａ
US5837458A (en) * 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US6930084B1 (en) 1996-11-06 2005-08-16 The Regents Of The University Of California Treating arthritis with TNF receptor releasing enzyme
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
CA2270898A1 (en) * 1996-11-06 1998-05-14 The Regents Of The University Of California Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof
US6989435B2 (en) * 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6406907B1 (en) * 1999-02-26 2002-06-18 Iowa State University Research Foundation Bovine tumor necrosis factor receptor-1 and methods of use
AU2001245371A1 (en) 2000-02-28 2001-09-12 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
WO2003046160A2 (en) * 2001-11-30 2003-06-05 Applied Research Systems Ars Holding N.V. Methods of increasing protein expression levels
AU2006315758A1 (en) * 2005-11-10 2007-05-24 Ercole Biotech, Inc. Splice switching oligomers for TNF superfamily receptors and their use in treatment of disease
US7785834B2 (en) * 2005-11-10 2010-08-31 Ercole Biotech, Inc. Soluble TNF receptors and their use in treatment of disease
WO2007134384A2 (en) * 2006-05-19 2007-11-29 Children Youth And Women's Health Service Selective modulation of receptor signalling
US20090264353A1 (en) * 2007-10-19 2009-10-22 Santaris Pharma A/S Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
WO2011049350A2 (ko) * 2009-10-19 2011-04-28 한올바이오파마주식회사 변형된 인간 종양 괴사 인자 수용체-1 폴리펩티드 또는 그의 절편 및 그의 제조방법
US10723532B2 (en) 2017-05-22 2020-07-28 Bedford Insutries, Inc. Elastic band package
US11021339B2 (en) 2017-05-22 2021-06-01 Bedford Industries, Inc. Elastic band dispenser

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101769A (en) * 1992-05-03 2007-02-11 Yeda Res & Dev Modulation of TNF receptor action

Also Published As

Publication number Publication date
DK0657536T3 (da) 2001-09-17
PT657536E (pt) 2001-12-28
EP0657536B1 (de) 2001-07-18
JPH07194376A (ja) 1995-08-01
US5665859A (en) 1997-09-09
EP0657536A1 (de) 1995-06-14
AU679559B2 (en) 1997-07-03
GR3036782T3 (en) 2002-01-31
US5766917A (en) 1998-06-16
ES2163418T3 (es) 2002-02-01
IL107268A0 (en) 1994-01-25
CA2133872A1 (en) 1995-04-13
AU7574294A (en) 1995-05-04
DE69427740T2 (de) 2002-05-23
ZA947962B (en) 1995-11-21
DE69427740D1 (de) 2001-08-23

Similar Documents

Publication Publication Date Title
ATE203273T1 (de) Inhibitoren einer protease, die den löslichen p55-tnf-rezeptor vom zellgebundenen tnf-rezeptor abspaltet
DK0662005T3 (da) Mikropartikelpræparater af biologisk nedbrydelige copolymerer
ATE426023T1 (de) ßHEDGEHOG-LIKEß PROTEINE VON WIRBELTIEREN, DIE EMBRYONALE STRUKTUREN INDUZIEREN
IT8320064A0 (it) Inibitori dell'enzima che trasforma l'angiotensina, costituiti da acidi amminoalchilfosfinici e da acidi amminofosfinici sostituiti simili.
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
RU95106682A (ru) Распределенная компьютерная система
ATE353640T1 (de) Antagoniste zur behandlung von cd11/cd18 adhäsionsrezeptor-vermittelten krankheiten
DE69525369D1 (de) Kontinuierliches polymerisationverfahren von polyamiden
IT1241549B (it) Procedimento per la produzione di valvole.
ATE412052T1 (de) Synthetische polynukleotide
NL8901652A (nl) Carboxamideverbindingen, werkwijzen ter bereiding hiervan en farmaceutische preparaten, die deze bevatten.
ATE307204T1 (de) Tumor-nekrose-faktor ähnliches ligand
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
BR9611897A (pt) Benzofurano carboxamidas e sulfonamidas
DE68919311D1 (de) Selbstinduzierte Reparatur von Leiterzügen.
DE69110713D1 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
DE68905055D1 (de) Binaer-ternaer-umsetzer zur kombination von zwei binaer-signalen.
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
DE59009112D1 (de) Scheinwerfer, der in seiner Helligkeit stufenlos regelbar ist.
FR2701264B1 (fr) Muteines de facteur de necrose tumorale.
CA2166692A1 (en) Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
DK0648783T3 (da) TNF-inhibitorer
DK179784A (da) Krystallinsk zinksilicat, fremgangsmaade til dets fremstilling samt dets anvendelse
HUP0002304A2 (hu) Állatok májából kivonható fehérjék alkalmazása tumor nekrózis faktor túltermelődéssel járó kóros állapotok kezelésére használható gyógyászati készítmények előállítására

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee